mifepristone has been researched along with Overweight in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Grewal, S; Gubbi, S; McGlotten, R; Muniyappa, R; Nieman, LK; Sharma, ST | 1 |
| Rasgon, NL; Roat-Shumway, S; Schatzberg, AF; Watson, K; Wroolie, TE | 1 |
| Mattsson, C; Olsson, T; Reynolds, RM; Simonyte, K; Walker, BR | 1 |
2 trial(s) available for mifepristone and Overweight
| Article | Year |
|---|---|
Mifepristone Improves Adipose Tissue Insulin Sensitivity in Insulin Resistant Individuals.
Topics: Adipose Tissue; Adult; Aged; Cross-Over Studies; Double-Blind Method; Female; Glucose Intolerance; Humans; Insulin Resistance; Insulin Secretion; Male; Middle Aged; Mifepristone; Obesity; Overweight; Prediabetic State; United States | 2021 |
Combined receptor antagonist stimulation of the hypothalamic-pituitary-adrenal axis test identifies impaired negative feedback sensitivity to cortisol in obese men.
Topics: Adult; Blood Pressure; Cross-Over Studies; Double-Blind Method; Feedback; Female; Hormone Antagonists; Humans; Hydrocortisone; Hypothalamo-Hypophyseal System; Male; Middle Aged; Mifepristone; Mineralocorticoid Receptor Antagonists; Obesity; Overweight; Pituitary-Adrenal System; Placebos; Receptors, Glucocorticoid; Receptors, Mineralocorticoid; Spironolactone; Waist-Hip Ratio | 2009 |
1 other study(ies) available for mifepristone and Overweight
| Article | Year |
|---|---|
Cognitive effects of mifepristone in overweight, euthymic adults with depressive disorders.
Topics: Aged; Attention; Blood Glucose; Cognition; Depressive Disorder, Major; Executive Function; Female; Glucose Tolerance Test; Hormone Antagonists; Humans; Hydrocortisone; Male; Memory; Middle Aged; Mifepristone; Neuropsychological Tests; Overweight; Verbal Learning | 2018 |